Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression

T. Hrncir, E. Trckova, L. Hrncirova

. 2024 ; 16 (21) : . [pub] 20241030

Language English Country Switzerland

Document type Journal Article

Grant support
20-09732S Czech Science Foundation
22-12533S Czech Science Foundation

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of MASLD. Methods: We utilized a human microbiota-associated mouse model, administering 10% fructose with or without preservatives for 11 weeks. Liver histology, hepatic gene expression (microarray analysis), biochemical markers, cytokine profiles, intestinal permeability, and gut microbiome composition (16S rRNA and Internal Transcribed Spacer (ITS) sequencing) were evaluated. Results: Fructose and potassium sorbate synergistically induced liver pathology characterized by increased steatosis, inflammation and fibrosis. These histological changes were associated with elevated liver function markers and altered lipid profiles. The treatments also induced significant changes in both the bacterial and fungal communities and disrupted intestinal barrier function, leading to increased pro-inflammatory responses in the mesenteric lymph nodes. Liver gene expression analysis revealed a wide range of transcriptional changes induced by fructose and modulated by the preservative. Key genes involved in lipid metabolism, oxidative stress, and inflammatory responses were affected. Conclusions: Our findings highlight the complex interactions between dietary components, gut microbiota, and host metabolism in the development of MASLD. The study identifies potential risks associated with the combined consumption of fructose and preservatives, particularly potassium sorbate. Our data reveal new mechanisms that are involved in the development of MASLD and open up a new avenue for the prevention and treatment of MASLD through dietary interventions and the modulation of the microbiome.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003761
003      
CZ-PrNML
005      
20250206104701.0
007      
ta
008      
250121s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu16213722 $2 doi
035    __
$a (PubMed)39519554
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hrncir, Tomas $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic $1 https://orcid.org/0000000160732412
245    10
$a Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression / $c T. Hrncir, E. Trckova, L. Hrncirova
520    9_
$a Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of MASLD. Methods: We utilized a human microbiota-associated mouse model, administering 10% fructose with or without preservatives for 11 weeks. Liver histology, hepatic gene expression (microarray analysis), biochemical markers, cytokine profiles, intestinal permeability, and gut microbiome composition (16S rRNA and Internal Transcribed Spacer (ITS) sequencing) were evaluated. Results: Fructose and potassium sorbate synergistically induced liver pathology characterized by increased steatosis, inflammation and fibrosis. These histological changes were associated with elevated liver function markers and altered lipid profiles. The treatments also induced significant changes in both the bacterial and fungal communities and disrupted intestinal barrier function, leading to increased pro-inflammatory responses in the mesenteric lymph nodes. Liver gene expression analysis revealed a wide range of transcriptional changes induced by fructose and modulated by the preservative. Key genes involved in lipid metabolism, oxidative stress, and inflammatory responses were affected. Conclusions: Our findings highlight the complex interactions between dietary components, gut microbiota, and host metabolism in the development of MASLD. The study identifies potential risks associated with the combined consumption of fructose and preservatives, particularly potassium sorbate. Our data reveal new mechanisms that are involved in the development of MASLD and open up a new avenue for the prevention and treatment of MASLD through dietary interventions and the modulation of the microbiome.
650    12
$a fruktosa $x škodlivé účinky $7 D005632
650    12
$a střevní mikroflóra $x účinky léků $7 D000069196
650    _2
$a zvířata $7 D000818
650    12
$a játra $x metabolismus $x účinky léků $7 D008099
650    _2
$a myši $7 D051379
650    _2
$a mužské pohlaví $7 D008297
650    12
$a potravinářské konzervační látky $x farmakologie $x škodlivé účinky $7 D005520
650    _2
$a kyselina sorbová $x farmakologie $7 D013011
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a ztučnělá játra $7 D005234
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a synergismus léků $7 D004357
650    _2
$a exprese genu $x účinky léků $7 D015870
655    _2
$a časopisecké články $7 D016428
700    1_
$a Trckova, Eva $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
700    1_
$a Hrncirova, Lucia $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 16, č. 21 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39519554 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104657 $b ABA008
999    __
$a ok $b bmc $g 2263504 $s 1239768
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 16 $c 21 $e 20241030 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a 20-09732S $p Czech Science Foundation
GRA    __
$a 22-12533S $p Czech Science Foundation
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...